Harran Üniversitesi Hastanesi dahiliye polikliniğine başvuranlarda anti-HCV pozitiflik sıklığı
Amaç: Bu çalışmada Harran Üniversitesi Hastanesi dahiliye polikliniğine başvuranlarda anti-HCV pozitiflik sıklığının belirlenmesi amaçlandı. Yöntem; Bilinen herhangi bir risk grubuna girmeyen iktersiz hastaların serumları anti-HCV antikorları yönünden incelendi. Bulgular: Tetkik edilen 947 serumun 18'inde (% 1.9) anti-HCV antikoru bulundu. Sonuç: Bulunan anti-HCV pozitiflik sıklığı, Avrupa ülkelerinde ve Türkiye'nin diğer yerlerinde bulunan oranlardan fazladır ve yaşla artış göstermektedir.
The frequency of anti-HCV positivity in whom applied to policlinics of internal medicine at Hospital of Harran University
Objective: In this study, it was aimed to determine the frequency of anti-HCV positivity in whom applied to policlinics of internal medicine at Hospital of Harran University. Methods: Blood samples were taken from patients who were not in any risk group and had no history of jaundice. 947 samples were investigated for anti-HCV antibodies. Results: In 1.9% of 947 persons, anti-HCV antibodies were detected. Conclusion: Hepatitis C infection was more common than in European countries and other regions of Turkey. There was a significant increase in anti-HCV positivity with aging.
___
- Kılıçturgay K. Akut viral hepatitler. Aktüel Tıp Derg 1997;2:19-23.
- Esteban R. Epidemiology of hepatitis C virus infection. J Hepatol 1993;17 Suppl 3:67-71.
- Çakaloğlu Y. Kronik viral hepatitislerin tedavisi: Yeni yaklaşımlar. Aktüel Tıp Derg 1997;2:25-9.
- Murphy EL, Bryzman S, Williams AE, Co-Chien H, Schreiber GB, Ownby HE, et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996;275:995-1000.
- Sönmez E. New approaches to hepatitis C virus infection. Turgut Özal Tıp Merkezi Derg 1995;2:383-90.
- Dökmetaş HS, Türkay C, Dökmetaş İ, İçağasıoğlu S, Topçu S, Poyraz Ö. Kronik karaciğer hastalıklarının etyolojisinde hepatit B, C ve delta virüslerinin rolü. Cumhuriyet Üniv Tıp Fak Derg 1995;17:261-4.
- Mabrouk GM. Prevalence of hepatitis C infection and schistosomiasis in Egyptian patients with hepatocellular carcinoma. Dis Markers 1997;12:177-82.
- Yönetici N, Akarsu US, Ersöz G, İşler M, Batur Y. Hepatosellüler kanser etyolojisinde hepatit virusları. Turk Gastroenterol 1996;7:127-30.
- Triverdi M. Newly diagnosed hepatitis C, lack of symptoms doesn't mean lack of progression. Postgrad Med 1997;102:95-8.
- Bayraktar Y, Colastoni A, De Maria N, Vanthiel DH. Hepatitis C: Current issues and the potential for feature progress. Turk Gastroenterol 1995;6:303-13.
- Degos F. Epidemiology of hepatitis C virus in Europe. FEMS Microbiol Rev 1994;14:267-72.
- Oshita M, Hayashi N, Kashara A, Yuki N, Takehara T, Hagiwara H, et al. Prevalence of hepatitis C virus in family members of patients with hepatitis C. J Med Virol 1993;41:251-5.
- Osella RA, Misciagna G, Leone A, Leo DA, Fiore G. Epidemiology of hepatitis C virus infection in an area of Southern Italy. J Hepatol 1997;27:30-5.
- Helvacı M, Çetemen A, Arus E, İsenlik S. Hepatit C. Yeni Tıp Derg 1997;14:223-4.
- Huraib S, Al Rashed R, Aldress A, Aljefry M, Arif M, Al Faleh FA. High prevalence of and risk factors for hepatitis C in hemodialysis patient in Saudi Arabia: A need for new dialysis strategies. Nephrol Dial Transplant 1995;10:470-4.
- Huaghan CC. Hepatitis in patients with end stage renal disease. J Gastroenterol Hepatol 1997;12:236-41.
- Struve J, Aransson B, Frenning B, Forsgren M, Weiland O. Prevalence of antibodies against hepatitis C virus infection among health care worker in Stockholm. Scand J Gastroenterol 1994;29:360-2.
- Paydas S, Aksu HS, Paydas S, Burgut R, Sagliker Y. The prevalence of anti-HCV positivity in patients undergoing haemodialysis or with malignant disease. Br J Clin Pract 1994;48:25-6.
- Thomas DL, Mahley RW, Badur S, Palaoğlu E, Quinn TC. The epidemiology of hepatitis C in Turkey. Infection 1994;22:411-4.
- Çağatay M, Tülek N, Köksalan H, Mert A. Hastane personelinde hepatit C virus antikor prevalansı. Mikrobiyol Bült 1992;26:242-7.
- Köksal İ, Biberoğlu K, Biberoğlu S, Koç F, Ayma Y, Aker F, et al. Hepatitis C virus antibodies among risk groups in Turkey. Infection 1991;19:228-9.
- Kocabaş E, Aksaray N, Alhan E, Yarkin F, Kilinc Y. Hepatitis B and C virus infections in Turkish children with hemofilia. Acta Pediatr 1997;86:1135-7.
- Froni A, Ragni MC, Salvaggio L, Vezzoli F. Hepatitis C virus. Lancet 1995;1:190.